Organovo (ONVO) Updates Investor FAQ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Organovo Holdings, Inc. To Present at Cantor Fitzgerald Inaugural Healthcare Conference
June 23, 2015 4:05 PM EDTSAN DIEGO, June 23, 2015 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, announced today that the company will present at the upcoming investor event, the Cantor Fitzgerald Inaugural Healthcare Conference, to be held in New York, July 8, 2015. Keith Murphy, Chairman and Chief Executive Officer, will deliver a company presentation. Mr. Murphy and Barry Michaels, Chief Financial Officer for Organovo, will be available for individual meetings with investors throughout the day.
Details of the presentations are as... More
